(682) 651-1112
(682) 651-1112
Operational excellence, specialty expertise and reliable data delivery.
Evidentis is a specialty clinical research center focused on liver, metabolic and cardiometabolic health, supported by early-phase capability and precise operational workflows. We partner with sponsors and CROs seeking high-quality data, efficient execution and engaged investigators with deep subspecialty expertise.
Our infrastructure supports Phase 1 through Phase 4 clinical trials, with strong emphasis on scientific rigor, participant safety, controlled workflows and responsive communication throughout the study lifecycle.
All studies are overseen by a triple board-certified principal investigator with extensive experience across NIH-funded, investigator-led, and industry-sponsored trials, ensuring consistent engagement and rigorous scientific oversight.
Our research team executes precise workflows, accurate data capture, and strict protocol adherence. PK timing, sample collection, and critical procedures are supported by controlled processes and real-time oversight to ensure reliable data delivery.
Evidentis leadership brings extensive experience across multicenter, investigator-initiated, and industry-sponsored Phase 2–4 trials in liver and metabolic disease.
Past & Current Clinical Trials
Evidentis maintains in-house data management and biostatistical oversight, led by an experienced data scientist who works closely with CRCs to support data accuracy, query resolution, PK workflows, and overall statistical quality.
Evidentis prioritizes rapid turnaround for feasibility review, regulatory submissions, contract and budget negotiation and IRB activation. Close coordination with sponsors and CROs supports predictable, streamlined startup timelines.
Evidentis benefits from strong referral pathways across the Dallas–Fort Worth region, including:
This network supports reliable recruitment across liver, metabolic and cardiometabolic conditions.
Evidentis operates a dedicated overnight research suite supporting early-phase studies and pharmacokinetic (PK) protocols, with:
This setup enables precise execution of 24-48 hour PK sampling and early-phase procedures in a controlled, participant-centered environment.
Sponsors and CROs receive timely updates, clear documentation and accessible PI and coordinator communication throughout the lifecycle of each trial.
Evidentis maintains research environments and laboratory infrastructure designed to support high-quality data collection across early- and later-phase clinical trials.
We provide efficient turnaround for:
Open communication throughout startup supports predictable, reliable timelines.
Our processes support:
All staff complete ongoing GCP, protocol-specific and role-specific training.
Submit your protocol synopsis, schedule of assessments or feasibility questionnaire, and our team will respond promptly.
Evidentis offers expert consulting for sponsors, CROs, clinical investigators and healthcare organizations seeking guidance in liver and metabolic clinical research. Areas include protocol input, early-phase design considerations, site-readiness planning, operational optimization and invited scientific talks.
Consulting services may be provided directly by the principal investigator and may include members of the Evidentis clinical and research team as appropriate to the engagement.
Enquiries: research@evidentisresearch.com
Evidentis is open to selective long-term partnerships that align with our research focus, operational standards and commitment to scientific rigor. These may include multicenter collaborations, co-developed research programs, shared infrastructure initiatives or disease-specific research networks.
Partnership discussions can be initiated by contacting: research@evidentisresearch.com